DENTISLtd Valuation
Is A261200 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of A261200 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von A261200 für die Bewertungsanalyse.
Deutlich unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von A261200 für die Bewertungsanalyse.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A261200?
Other financial metrics that can be useful for relative valuation.
What is A261200's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩137.19b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | 41x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does A261200's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 17.3x | ||
A104540 Corentec | 34.3x | n/a | ₩139.1b |
A065510 Huvitz | 12.2x | 39.2% | ₩143.2b |
A228850 Rayence | 7.2x | 7.2% | ₩141.6b |
A149980 Hironic | 15.7x | n/a | ₩128.9b |
A261200 DENTISLtd | 35.8x | n/a | ₩137.2b |
Price-To-Earnings gegen Gleichaltrige: A261200 ist auf der Grundlage des Price-To-Earnings Verhältnisses (36.4x) im Vergleich zum Durchschnitt der Vergleichsgruppe (10.3x) teuer.
Price to Earnings Ratio vs Industry
How does A261200's PE Ratio compare vs other companies in the KR Medical Equipment Industry?
Price-To-Earnings gegen Industrie: A261200 ist teuer, wenn man sein Price-To-Earnings Verhältnis (36.4x) mit dem KR Medical Equipment Branchendurchschnitt (15.2x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is A261200's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 35.8x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von A261200 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.